plantbased
Commented by André Will-Laudien on August 12th, 2026 | 08:05 CEST
Heat, Drought, and Water Shortages: A Sector-Wide Buy Signal for Environmental Specialists Bayer, MustGrow, Kraft Heinz and Unilever
Created and Published on Behalf of MustGrow Biologics Corp.
The devastating combination of persistent drought, acute water shortages, and extreme heat is creating unprecedented challenges for the global economy and food supply. As climate-related risks intensify, ESG considerations are moving into sharper focus than ever before. Amid this crisis, a potential technical and fundamental buy signal is emerging across sectors for companies capable of delivering innovative environmental solutions. Agricultural and chemical companies such as Bayer are developing advanced seed technologies designed to make crops more resilient during periods of extreme drought. At the same time, the AgriTech company MustGrow is gaining importance as its biological fertilizer and crop protection solutions are designed to protect soil health and improve water efficiency in agriculture, among other things. Food giants such as Unilever and Kraft Heinz are also responding proactively by strictly optimizing their entire supply chains to minimize water consumption and resource intensity. Investors are increasingly recognizing that sustainable business practices in modern times are no longer merely an image factor, but rather a catalyst for future returns.
Read
Commented by Nico Popp on August 4th, 2026 | 11:00 CEST
Agribusiness Sector Heats Up: BASF, MustGrow Biologics, and Corteva—Where Growth Is Scaling and What Analysts Recommend
Created and Published on Behalf of MustGrow Biologics Corp.
Investments in the agribusiness sector are often viewed as resilient long-term opportunities, driven by steadily growing global food demand. However, the industry's outlook is becoming increasingly complex. Climate change and tightening regulations are forcing agricultural companies to adapt continuously. To feed an estimated 9.7 billion people by 2050, experts believe global food production must increase significantly despite a shrinking amount of arable land. At the same time, regulators around the world are moving to phase out conventional crop protection products. The EU aims to have 25% of agricultural land under organic farming by 2030 and has already banned many conventional crop protection products. These developments are creating significant opportunities for biological alternatives. We take a closer look at the market and the companies best positioned to benefit from these long-term trends.
Read
Commented by Nico Popp on October 31st, 2025 | 07:00 CET
Health as a billion-dollar market: PanGenomic Health, Hims & Hers, WW International
More and more people are taking a proactive approach to their health, with prevention and self-care trending. According to recent studies by McKinsey, the global wellness industry is now valued at around USD 2 trillion. Younger generations in particular are integrating health firmly into their lifestyles: nearly 30% of millennials and Gen Z in the US report that they are doing significantly more for their well-being today than they were a year ago. Instead of only taking action when they fall ill, many are focusing on prevention, digital health tools, and online communities for support and exchange. We take a look at the latest trends, revisit familiar names, and highlight an emerging startup that could also deliver healthy returns for your portfolio.
Read
Commented by Fabian Lorenz on October 16th, 2025 | 07:05 CEST
Takeover fever and AI Opportunities: BioNTech, Novo Nordisk, PanGenomic Health
The pharmaceutical and biotech sector is buzzing with takeover activity. Following the announcement of a billion-dollar acquisition in the US, Novo Nordisk has announced its next deal, eyeing a potential best-in-class therapeutic for several rare diseases. Meanwhile, PanGenomic Health is positioning itself in the billion-dollar market for alternative medicine and dietary supplements, leveraging AI to provide added value to customers and capture market share. If successful, the stock could be significantly undervalued. BioNTech's acquisition of CureVac has now been completed, ending CureVac's period of suffering. In the process, BioNTech secures patents and elegantly resolves ongoing legal disputes.
Read
Commented by Armin Schulz on October 10th, 2025 | 07:15 CEST
From food waste to profit: How Nestlé, Planethic Group, and HelloFresh are capitalizing on the latest megatrends
The food industry is currently undergoing what may be the most lucrative revolution in its history. Driven by groundbreaking technologies, from 2D printing for food to the hype surrounding plant-based proteins, and the global drive to curb food waste, entirely new markets are emerging. By keeping an eye on the companies driving these megatrends, you can identify the major growth opportunities of the future at an early stage. Today, we take a close look at the strategies of Nestlé, Planethic Group, and HelloFresh and ask ourselves: Which stocks really have what it takes to succeed?
Read